COVID-19 & CancerFree COVID-19 and cancer: AACR convenes a meeting to explore a research agenda July 17, 2020Vol.46 No.29By Alexandria Carolan
COVID-19 UpdatesFree Yale researchers identify COVID-19 blood clotting cause July 10, 2020Vol.46 No.28
Conversation with The Cancer LetterCOVID-19 & CancerFree Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio July 10, 2020Vol.46 No.28By Paul Goldberg
Clinical RoundupFree NCCN Guidelines for patients can help patients recognize side-effects of immunotherapy July 02, 2020Vol.46 No.27
COVID-19 & CancerFreeTrials & Tribulations (Social + geographic) distance = Ongoing challenges in disparities for rural cancer patients July 02, 2020Vol.46 No.27By Jennifer Dill, Marsha Kutter and Peggy Wisher
Conversation with The Cancer LetterCOVID-19 & CancerFree Northwell Health reopens cancer services after COVID-19 delugeNew York health system explores NCI designation in affiliation with Cold Spring Harbor Laboratory July 02, 2020Vol.46 No.27By Paul Goldberg
Drugs & TargetsFree FDA approves Keytruda for cutaneous squamous cell carcinoma June 26, 2020Vol.46 No.26
Drugs & TargetsFree Selinexor receives FDA approval for relapsed/refractory diffuse large B-cell lymphoma June 26, 2020Vol.46 No.26
